Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

Clinical trial NCT06031194 · COMPLETED

Trial details

NCT number: NCT06031194
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

Central Nervous System Lymphoma Diffuse Large B-Cell Lymphoma

Start date: 2023-05-10
Primary completion: 2025-11-05
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.